{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:26:27Z","timestamp":1775107587001,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04581-z","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:57:26Z","timestamp":1775102246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neglected GLP-1 receptors in the eyes and nose: possible correlation with regulation of appetite"],"prefix":"10.1007","volume":"91","author":[{"given":"A.","family":"Saturnino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5090-636X","authenticated-orcid":false,"given":"P.","family":"Pozzilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"7","key":"4581_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/obr.12551","volume":"18","author":"G.A. Bray","year":"2017","unstructured":"G.A. Bray, K.K. Kim, J.P.H. Wilding, Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes. Rev. 18(7), 715\u2013723 (2017). https:\/\/pubmed.ncbi.nlm.nih.gov\/28489290\/","journal-title":"Obes. Rev."},{"issue":"11","key":"4581_CR2","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2337\/dci24-0003","volume":"47","author":"D.J. Drucker","year":"2024","unstructured":"D.J. Drucker, Efficacy, and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity. Diabetes care. 47(11), 1873\u20131888 (2024). https:\/\/diabetesjournals.org\/care\/article\/47\/11\/1873\/156807\/Efficacy-and-Safety-of-GLP-1-Medicines-for-Type-2","journal-title":"Diabetes care"},{"key":"4581_CR3","doi-asserted-by":"crossref","unstructured":"M. Salehi, J.Q. Purnell, The Role of Glucagon-Like Peptide-1 in Energy Homeostasis (Metabolic Syndrome and Related Disorders, 2019)","DOI":"10.1089\/met.2018.0088"},{"key":"4581_CR4","doi-asserted-by":"publisher","first-page":"171179","DOI":"10.1016\/j.peptides.2024.171179","volume":"175","author":"A.H. Shilleh","year":"2024","unstructured":"A.H. Shilleh, K. Viloria, J.E. Johannes Broichhagen, Campbell, D.J. Hodson,. GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells. Peptides. 175, 171179\u2013171179 (2024). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0196978124000329","journal-title":"Peptides"},{"issue":"4","key":"4581_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bph.15611","volume":"179","author":"JJ Holst","year":"2021","unstructured":"J.J. Holst, D.B. Andersen, K.V. Grunddal, Actions of glucagon-like peptide\u20101 receptor ligands in the gut. Br. J. Pharmacol. 179(4), 727\u2013742 (2021)","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"4581_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/ijms20040889","volume":"20","author":"E Howell","year":"2019","unstructured":"E. Howell, H. Baumgartner, L. Zallar, J. Selva, L. Engel, P. Currie, Glucagon-Like Peptide-1 (GLP-1) and 5-Hydroxytryptamine 2c (5-HT2c) receptor agonists in the ventral tegmental area (VTA) inhibit Ghrelin-Stimulated appetitive reward. Int. J. Mol. Sci. 20(4), 889 (2019)","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"4581_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5483\/BMBRep.2015.48.4.272","volume":"48","author":"J.W. Sohn","year":"2015","unstructured":"J.W. Sohn, Network of hypothalamic neurons that control appetite. BMB Rep. 48(4), 229\u2013233 (2015). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4436859\/","journal-title":"BMB Rep."},{"issue":"1","key":"4581_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","volume":"34","author":"M.R. Hayes","year":"2014","unstructured":"M.R. Hayes, E.G. Mietlicki-Baase, S.E. Kanoski, B.C. De, Jonghe, Incretins and Amylin: Neuroendocrine Communication Between the Gut, Pancreas, and Brain in Control of Food Intake and Blood Glucose. Annu. Rev. Nutr. 34(1), 237\u2013260 (2014). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4458367\/","journal-title":"Annu. Rev. Nutr."},{"issue":"6","key":"4581_CR9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s10571-021-01080-9","volume":"42","author":"M.A. Guzm\u00e1n-Ruiz","year":"2022","unstructured":"M.A. Guzm\u00e1n-Ruiz, A. Jim\u00e9nez, A. C\u00e1rdenas-Rivera, N.N. Guerrero-Vargas, D. Organista-Ju\u00e1rez, R. Guevara-Guzm\u00e1n, Regulation of Metabolic Health by an Olfactory-Hypothalamic Axis and Its Possible Implications for the Development of Therapeutic Approaches for Obesity and T2D. Cellular and molecular neurobiology. 42(6), 1727\u20131743 (2022). https:\/\/pubmed.ncbi.nlm.nih.gov\/33813677\/","journal-title":"Cellular and molecular neurobiology"},{"key":"4581_CR10","doi-asserted-by":"publisher","first-page":"117811","DOI":"10.1016\/j.neuroimage.2021.117811","volume":"230","author":"R Janet","year":"2021","unstructured":"R. Janet, A. Fournel, M. Fouillen, E. Derrington, B. Corgnet, M. Bensafi et al., Cognitive and hormonal regulation of appetite for food presented in the olfactory and visual modalities. NeuroImage. 230, 117811 (2021)","journal-title":"NeuroImage"},{"key":"4581_CR11","doi-asserted-by":"publisher","first-page":"bjad039","DOI":"10.1093\/chemse\/bjad039","volume":"48","author":"Y. Zhao","year":"2023","unstructured":"Y. Zhao, S. Bhutani, T. Kahnt, Appetite-regulating hormones modulate odor perception and odor-evoked activity in hypothalamus and olfactory cortices. Chem. Senses. 48, bjad039 (2023)","journal-title":"Chem. Senses"},{"issue":"4","key":"4581_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1056\/NEJMra2402679","volume":"392","author":"A Fasano","year":"2025","unstructured":"A. Fasano, The physiology of hunger. N. Engl. J. Med. 392(4), 372\u2013381 (2025)","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"4581_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3758\/s13423-020-01843-3","volume":"28","author":"K Chan","year":"2020","unstructured":"K. Chan, R.J. Stevenson, H. Francis, The nose is hungrier than the eyes. Psychon. Bull. Rev. 28(2), 657\u2013664 (2020)","journal-title":"Psychon. Bull. Rev."},{"issue":"6707","key":"4581_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1126\/science.adj2537","volume":"385","author":"K.S. Kim","year":"2024","unstructured":"K.S. Kim, J.S. Park, E. Hwang, H.Y. Min Jung Park, Y.H. Shin, GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans. Science. 385(6707), 438\u2013446 (2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/38935778\/","journal-title":"Science"},{"issue":"1","key":"4581_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13578-022-00914-3","volume":"12","author":"I. Singh","year":"2022","unstructured":"I. Singh, L. Wang, B. Xia, J. Liu, A. Tahiri, A. El, Ouaamari et al., Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake. Cell. Bioscience. 12(1), 178 (2022)","journal-title":"Cell. Bioscience"},{"issue":"5","key":"4581_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40265-017-0706-4","volume":"77","author":"B. de Geloneze","year":"2017","unstructured":"B. Geloneze, de J.C. Lima-J\u00fanior, L.A. Velloso, Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain\u2013Adipocyte Axis. Drugs. 77(5), 493\u2013503 (2017) https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5357258\/","journal-title":"Drugs"},{"issue":"3","key":"4581_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.ijo.0800818","volume":"23","author":"E. N\u00e4slund","year":"1999","unstructured":"E. N\u00e4slund, B. Barkeling, N. King, M. Gutniak, J.E. Blundell, J.J. Holst et al., Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. 23(3), 304\u2013311 (1999). https:\/\/www.nature.com\/articles\/0800818","journal-title":"Int. J. Obes."},{"issue":"1","key":"4581_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/gidisord7010003","volume":"7","author":"J. van Wilbrink","year":"2024","unstructured":"J. Wilbrink, M. van Avesaat, A. Stronkhorst, F. Troost, Roux le, Ad Masclee. Peptide YY and Glucagon-like Peptide-1 Secretion in Obesity. Gastrointest. Disorders. 7(1), 3\u20133 (2024). https:\/\/www.mdpi.com\/2624-5647\/7\/1\/3","journal-title":"Gastrointest. Disorders"},{"issue":"7","key":"4581_CR19","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.2337\/db14-1751","volume":"64","author":"K F\u00e6rch","year":"2015","unstructured":"K. F\u00e6rch, S.S. Torekov, D. Vistisen, N.B. Johansen, D.R. Witte, A. Jonsson et al., GLP-1 response to oral glucose is reduced in Prediabetes, Screen-Detected type 2 Diabetes, and obesity and influenced by sex: the ADDITION-PRO study. Diabetes. 64(7), 2513\u20132525 (2015)","journal-title":"Diabetes"},{"issue":"3","key":"4581_CR20","doi-asserted-by":"publisher","first-page":"e3755","DOI":"10.1002\/dmrr.3755","volume":"40","author":"M. Ibrahim","year":"2023","unstructured":"M. Ibrahim, E.M. Ba-Essa, J. Baker, A. Cahn, A. Ceriello, F. Cosentino et al., Cardio\u2010renal\u2010metabolic disease in primary care setting. Diab \/Metab Res. Rev. 40(3), e3755 (2023)","journal-title":"Diab \/Metab Res. Rev."},{"issue":"1","key":"4581_CR21","doi-asserted-by":"publisher","first-page":"e70017","DOI":"10.1002\/dmrr.70017","volume":"41","author":"A. Saturnino","year":"2025","unstructured":"A. Saturnino, E. Maddaloni, S. Zampetti, R. Buzzetti, Searching the Crystal Ball for Tailored GLP-1 Receptor Agonists Treatment in Type 2 Diabetes and Obesity. Diab.\/Metab. Res. Rev. 41(1), e70017 (2025)https:\/\/pubmed.ncbi.nlm.nih.gov\/39673731\/","journal-title":"Diab.\/Metab. Res. Rev."},{"key":"4581_CR22","doi-asserted-by":"crossref","unstructured":"E.E. Connor, Y. Zhou, G.E. Liu, The essence of appetite: does olfactory receptor variation play a role? Journal of Animal Science. 96(4):1551\u20131558 (2018). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6140904\/","DOI":"10.1093\/jas\/sky068"},{"issue":"1","key":"4581_CR23","doi-asserted-by":"publisher","first-page":"7892","DOI":"10.1038\/s41467-025-63170-2","volume":"16","author":"Y. Liu","year":"2025","unstructured":"Y. Liu, H. Liu, H.X.K. Wong, N. Auld, K.M. Conde, Y. Li et al., Prolonged exposure to food odors suppresses feeding via an olfactory bulb-to-hypothalamus circuit. Nat. Commun. 16(1), 7892 (2025). https:\/\/www.nature.com\/articles\/s41467-025-63170-2","journal-title":"Nat. Commun."},{"issue":"1","key":"4581_CR24","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1038\/s41467-024-51076-4","volume":"15","author":"M. Montaner","year":"2024","unstructured":"M. Montaner, J. Denom, V. Simon, W. Jiang, M.K. Holt, D.I. Brierley et al., A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion. Nat. Commun. 15(1), 6941 (2024). https:\/\/www.nature.com\/articles\/s41467-024-51076-4","journal-title":"Nat. Commun."},{"key":"4581_CR25","doi-asserted-by":"publisher","first-page":"101738","DOI":"10.1016\/j.molmet.2023.101738","volume":"73","author":"M. Montaner","year":"2023","unstructured":"M. Montaner, J. Denom, W. Jiang, C. Magnan, S. Trapp, H. Gurden, The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice. Mol. metabolism. 73, 101738 (2023). https:\/\/pubmed.ncbi.nlm.nih.gov\/37182561\/","journal-title":"Mol. metabolism"},{"issue":"1","key":"4581_CR26","doi-asserted-by":"publisher","first-page":"13978","DOI":"10.1038\/s41598-017-14086-5","volume":"7","author":"K.S. Kim","year":"2017","unstructured":"K.S. Kim, I.S. Lee, K.H. Kim, J. Park, Y. Kim, J.H. Choi et al., Activation of intestinal olfactory receptor stimulates glucagon-like peptide-1 secretion in enteroendocrine cells and attenuates hyperglycemia in type 2 diabetic mice. Sci. Rep. 7(1), 13978 (2017)","journal-title":"Sci. Rep."},{"key":"4581_CR27","doi-asserted-by":"publisher","first-page":"824054","DOI":"10.3389\/fnins.2022.824054","volume":"16","author":"Z.A. Mouhammad","year":"2022","unstructured":"Z.A. Mouhammad, R. Vohra, A. Horwitz, A.S. Thein, J. Rovelt, B. Cvenkel et al., Glucagon-Like peptide 1 receptor Agonists \u2013 Potential game changers in the treatment of glaucoma? Front. NeuroSci. 16, 824054 (2022)","journal-title":"Front. NeuroSci."},{"issue":"20","key":"4581_CR28","doi-asserted-by":"publisher","first-page":"12428","DOI":"10.3390\/ijms232012428","volume":"23","author":"A. Puddu","year":"2022","unstructured":"A. Puddu, D. Maggi, Anti-Inflammatory Effects of GLP-1R Activation in the Retina. Int. J. Mol. Sci. 23(20), 12428 (2022) https:\/\/doi.org\/10.3390\/ijms232012428","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"4581_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamaophthalmol.2024.6555","volume":"143","author":"C.X. Cai","year":"2025","unstructured":"C.X. Cai, M. Hribar, S. Baxter, K. Goetz, S.S. Swaminathan, A. Flowers et al., Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. JAMA Ophthalmol. 143(4), 304\u2013314 (2025). https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2830475","journal-title":"JAMA Ophthalmol."},{"issue":"8","key":"4581_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","volume":"142","author":"J.T. Hathaway Jr","year":"2024","unstructured":"J.T. Hathaway, M.P. Shah, D.B. Hathaway, S.M. Zekavat, D. Krasniqi, J.W. Jr Gittinger et al., Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide. JAMA Ophthalmol. 142(8), 732\u2013739 (2024). https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/article-abstract\/2820255","journal-title":"JAMA Ophthalmol."},{"key":"4581_CR31","doi-asserted-by":"crossref","unstructured":"Z. Liu BBiomed, D. Raveendran, S. Fourlanos, E.W. Chong, Rate and risk of non-arteritic anterior ischaemic optic neuropathy with semaglutide use for diabetes and weight loss: a systematic review and meta-analysis. Ophthalmology. S0161-6420(25)008036 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/41475544\/","DOI":"10.1016\/j.ophtha.2025.12.022"},{"key":"4581_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajo.2025.02.025","volume":"274","author":"N.J. Abbass","year":"2025","unstructured":"N.J. Abbass, J.K. Raya Nahlawi, K.C. Shaia, D.C. Allan, K.E. Kaelber, Talcott et al., The effect of semaglutide and GLP-1 RAs on risk of Non-Arteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 274, 24\u201331 (2025)","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"4581_CR33","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.diabet.2025.101664","volume":"51","author":"S Feldman-Billard","year":"2025","unstructured":"S. Feldman-Billard, What the diabetologist needs to know about the risk of non-arteritic anterior ischaemic optic neuropathy and GLP-1 receptor agonist use in patients with type 2 diabetes. Diabetes Metab. 51(4), 101664 (2025)","journal-title":"Diabetes Metab."},{"issue":"6","key":"4581_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/aos.17473","volume":"103","author":"A. Amini","year":"2025","unstructured":"A. Amini, S. Hamann, M. Larsen, Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association. Acta Ophthalmol. 103(6), 615\u2013621 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/40055951\/","journal-title":"Acta Ophthalmol."},{"key":"4581_CR35","unstructured":"Y. Sun, Y. Zhang, F. Shi, Y. Li, C. Wang, F. Yu et al., Characterization and Role of Glucagon-Like Peptide 1 Receptor in the Lacrimal Gland: Novel Insights into Diabetic Dry Eye Pathogenesis. The American journal of pathology. S0002-9440(24)004759 (2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/39725294\/"},{"key":"4581_CR36","doi-asserted-by":"crossref","unstructured":"D D. The Structure and Function of the Glucagon-Like peptide-1 Receptor and Its Ligands. Br. J. Pharmacol. 166(1):27-41 (2012). https:\/\/pubmed.ncbi.nlm.nih.gov\/21950636\/","DOI":"10.1111\/j.1476-5381.2011.01687.x"},{"issue":"9","key":"4581_CR37","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1111\/dom.13339","volume":"20","author":"J.B. Hebsgaard","year":"2018","unstructured":"J.B. Hebsgaard, C. Pyke, E. Yildirim, L.B. Knudsen, S. Heegaard, P.H. Kvist, Glucagon-like peptide-1 receptor expression in the human eye. Diabetes Obes. Metab. 20(9), 2304\u20132308 (2018). https:\/\/pubmed.ncbi.nlm.nih.gov\/29707863\/","journal-title":"Diabetes Obes. Metab."},{"issue":"7657","key":"4581_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature22394","volume":"546","author":"Y Zhang","year":"2017","unstructured":"Y. Zhang, B. Sun, D. Feng, H. Hu, M. Chu, Q. Qu et al., Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature. 546(7657), 248\u2013253 (2017)","journal-title":"Nature"},{"issue":"2","key":"4581_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1210\/en.2009-1002","volume":"151","author":"T.P. Vahl","year":"2010","unstructured":"T.P. Vahl, D.L. Drazen, R.J. Seeley, D.A. D\u2019Alessio, S.C. Woods, Meal-anticipatory glucagon-like peptide-1 secretion in rats. Endocrinology. 151(2), 569\u2013575 (2010). https:\/\/pubmed.ncbi.nlm.nih.gov\/19915164\/","journal-title":"Endocrinology"},{"issue":"8","key":"4581_CR40","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.3390\/ijms26083897","volume":"26","author":"S. Sayers","year":"2025","unstructured":"S. Sayers, E. Wagner, On the Pleiotropic Actions of Glucagon-like Peptide-1 in Its Regulation of Homeostatic and Hedonic Feeding. Int. J. Mol. Sci. 26(8), 3897 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/40332762\/","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"4581_CR41","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.neuron.2017.09.042","volume":"96","author":"J Liu","year":"2017","unstructured":"J. Liu, K. Conde, P. Zhang, V. Lilascharoen, Z. Xu, B.K. Lim et al., Enhanced AMPA receptor trafficking mediates the anorexigenic effect of endogenous Glucagon-like Peptide-1 in the paraventricular hypothalamus. Neuron. 96(4), 897\u2013909e5 (2017)","journal-title":"Neuron"},{"issue":"7","key":"4581_CR42","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/17425247.2024.2387110","volume":"21","author":"T Tabassum","year":"2024","unstructured":"T. Tabassum, Z. Sheikh, F. Simin Maleknia, A. Oveissi, Fathi, T. Abrams et al., Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges. Expert Opin. Drug Deliv. 21(7), 1081\u20131101 (2024)","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"4581_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db15-0443","volume":"65","author":"C. Hern\u00e1ndez","year":"2015","unstructured":"C. Hern\u00e1ndez, P. Bogdanov, L. Corraliza, M. Garc\u00eda-Ram\u00edrez, C. Sol\u00e0-Adell, J.A. Arranz et al., Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes. Diabetes. 65(1), 172\u2013187 (2015). https:\/\/diabetesjournals.org\/diabetes\/article\/65\/1\/172\/34979\/Topical-Administration-of-GLP-1-Receptor-Agonists","journal-title":"Diabetes"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04581-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04581-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04581-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:57:33Z","timestamp":1775102253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04581-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4581"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04581-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"130"}}